MedPath

JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMET L.L.C.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of JNJ-38431055 in Volunteers With Type 2 Diabetes Mellitus

Phase 1
Terminated
Conditions
Diabetes Mellitus, Type 2
First Posted Date
2009-07-27
Last Posted Date
2010-03-05
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
33
Registration Number
NCT00946972

An Efficacy and Safety Study of JNJ-38518168 in Adult Participants With Rheumatoid Arthritis

Phase 2
Terminated
Conditions
Rheumatoid Arthritis
Interventions
Drug: Placebo
First Posted Date
2009-07-20
Last Posted Date
2013-04-23
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
86
Registration Number
NCT00941707

A Clinical Study to Investigate the Effect on Pain Relief of a Single Dose of JNJ-39439335 in Patients With Chronic Osteoarthritis Pain of the Knee

Phase 1
Completed
Conditions
Osteoarthritis, Knee
First Posted Date
2009-07-07
Last Posted Date
2010-08-02
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
33
Registration Number
NCT00933582

Evaluating the Risk of Serious Ventricular Arrhythmia and Sudden Cardiac Death Among Users of Domperidone

Completed
Conditions
Arrhythmias, Cardiac
Interventions
Other: No Intervention
Drug: Current proton pump inhibitor (PPI)
First Posted Date
2009-06-22
Last Posted Date
2016-07-19
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
1608
Registration Number
NCT00925457

A Drug Interaction Study of JNJ-31001074 and Ketoconazole in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
Pharmacokinetics
Drug Interactions
First Posted Date
2009-06-08
Last Posted Date
2010-04-30
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
14
Registration Number
NCT00915746

A Study to Characterize the Pharmacokinetics and Effect of Food on JNJ-31001074 in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
Pharmacokinetics
First Posted Date
2009-06-08
Last Posted Date
2010-04-26
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
20
Registration Number
NCT00915434

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-38431055 in Healthy Male Volunteers

Phase 1
Completed
Conditions
Diabetes Mellitus, Type 2
First Posted Date
2009-06-01
Last Posted Date
2009-10-06
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
37
Registration Number
NCT00910923

A Bioequivalence Study of 15 mg ER OROS Paliperidone

Phase 1
Completed
Conditions
Schizophrenia
First Posted Date
2009-05-04
Last Posted Date
2011-06-08
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
80
Registration Number
NCT00892489

A Study of the Potential Effects of Trimethoprim on the Pharmacokinetics of ER OROS Paliperidone

Phase 1
Completed
Conditions
Schizophrenia
First Posted Date
2009-05-04
Last Posted Date
2011-06-08
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
30
Registration Number
NCT00892541
© Copyright 2025. All Rights Reserved by MedPath